PFKL
Basic information
Region (hg38): 21:44300051-44327376
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PFKL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 40 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 3 | |||||
Total | 0 | 0 | 41 | 10 | 7 |
Variants in PFKL
This is a list of pathogenic ClinVar variants found in the PFKL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-44300101-C-T | Benign (Oct 04, 2017) | |||
21-44300136-G-A | not specified | Uncertain significance (Mar 31, 2023) | ||
21-44300142-G-T | not specified | Uncertain significance (Jun 23, 2023) | ||
21-44305823-C-T | Benign (Oct 17, 2017) | |||
21-44305863-C-T | PFKL-related disorder | Benign (Jun 05, 2020) | ||
21-44306750-A-G | not specified | Uncertain significance (Nov 25, 2024) | ||
21-44311013-A-G | not specified | Uncertain significance (Apr 30, 2024) | ||
21-44311021-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
21-44311072-A-G | not specified | Uncertain significance (Feb 26, 2024) | ||
21-44312129-C-T | not specified | Uncertain significance (Sep 20, 2024) | ||
21-44312152-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
21-44312160-G-A | not specified | Uncertain significance (May 17, 2023) | ||
21-44312165-G-A | not specified | Likely benign (May 23, 2023) | ||
21-44312192-G-A | not specified | Uncertain significance (Jul 25, 2024) | ||
21-44312210-G-A | Uncertain significance (May 13, 2018) | |||
21-44312233-C-T | not specified | Benign (Jan 09, 2019) | ||
21-44312996-C-T | not specified | Uncertain significance (Oct 01, 2024) | ||
21-44313002-G-A | not specified | Likely benign (Aug 16, 2021) | ||
21-44313003-G-C | PFKL-related disorder | Likely benign (Mar 22, 2023) | ||
21-44313022-A-G | not specified | Uncertain significance (Aug 27, 2024) | ||
21-44313653-C-T | Likely benign (Sep 01, 2024) | |||
21-44313681-G-A | not specified | Uncertain significance (Nov 13, 2023) | ||
21-44313947-G-C | not specified | Uncertain significance (Oct 07, 2024) | ||
21-44313984-A-T | not specified | Benign (Nov 15, 2018) | ||
21-44313986-G-A | not specified | Uncertain significance (Aug 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PFKL | protein_coding | protein_coding | ENST00000349048 | 22 | 27326 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.70e-17 | 0.208 | 125625 | 0 | 84 | 125709 | 0.000334 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.68 | 403 | 510 | 0.791 | 0.0000346 | 5012 |
Missense in Polyphen | 173 | 237.93 | 0.72709 | 2234 | ||
Synonymous | -0.275 | 224 | 219 | 1.02 | 0.0000170 | 1566 |
Loss of Function | 1.37 | 31 | 40.4 | 0.767 | 0.00000191 | 458 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000804 | 0.000786 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000345 | 0.000326 |
Finnish | 0.000150 | 0.000139 |
European (Non-Finnish) | 0.000378 | 0.000369 |
Middle Eastern | 0.000345 | 0.000326 |
South Asian | 0.000446 | 0.000425 |
Other | 0.000196 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis (PubMed:22923583). Negatively regulates the phagocyte oxidative burst in response to bacterial infection by controlling cellular NADPH biosynthesis and NADPH oxidase-derived reactive oxygen species. Upon macrophage activation, drives the metabolic switch toward glycolysis, thus preventing glucose turnover that produces NADPH via pentose phosphate pathway (By similarity). {ECO:0000250|UniProtKB:P12382, ECO:0000255|HAMAP-Rule:MF_03184, ECO:0000269|PubMed:22923583}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);Fructose and mannose metabolism - Homo sapiens (human);Central carbon metabolism in cancer - Homo sapiens (human);HIF-1 signaling pathway - Homo sapiens (human);RNA degradation - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Pentose phosphate pathway - Homo sapiens (human);Warburg Effect;Pentose Phosphate Pathway;Fructose intolerance, hereditary;Glucose-6-phosphate dehydrogenase deficiency;Ribose-5-phosphate isomerase deficiency;Transaldolase deficiency;Fructose and Mannose Degradation;Fructosuria;Photodynamic therapy-induced HIF-1 survival signaling;Pathways in clear cell renal cell carcinoma;Insulin Signaling;Glycolysis and Gluconeogenesis;Neutrophil degranulation;phosphoinositides and their downstream targets;Metabolism of carbohydrates;Glycolysis Gluconeogenesis;Glycolysis and Gluconeogenesis;Innate Immune System;Immune System;Metabolism;Pentose phosphate cycle;Glycolysis;Galactose metabolism;glycolysis;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle;Glucose metabolism;HIF-1-alpha transcription factor network
(Consensus)
Recessive Scores
- pRec
- 0.435
Intolerance Scores
- loftool
- 0.507
- rvis_EVS
- -1.3
- rvis_percentile_EVS
- 4.95
Haploinsufficiency Scores
- pHI
- 0.187
- hipred
- Y
- hipred_score
- 0.533
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.953
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pfkl
- Phenotype
Gene ontology
- Biological process
- fructose 6-phosphate metabolic process;glucose catabolic process;glycolytic process;response to glucose;fructose 1,6-bisphosphate metabolic process;neutrophil degranulation;negative regulation of insulin secretion;protein complex oligomerization;protein homotetramerization;canonical glycolysis
- Cellular component
- extracellular region;cytosol;6-phosphofructokinase complex;membrane;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen
- Molecular function
- 6-phosphofructokinase activity;protein binding;ATP binding;AMP binding;kinase binding;identical protein binding;metal ion binding;monosaccharide binding;fructose binding;fructose-6-phosphate binding